A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma
Clinical trial NCT05036681 · TERMINATED
Trial details
- NCT number
- NCT05036681
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-30
- Primary completion
- 2024-09-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.